BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Concordia Announces Receipt of Nasdaq Initial Notice of Bid Price Requirement

  The Company’s common shares traded below a bid price of US$1.00 for 30 consecutive business days from October 17, 2017, to November 28, 2017.

  December 1, 2017

   · 

  5 min read
• Prometic Announces the Closing of its $80M Line of Credit With Structured Alpha LP, an Affiliate of Thomvest Asset Management

  As partial consideration for establishing the Credit Facility, Prometic has granted Structured Alpha LP an initial 10 million warrants with an exercise price of CAD $1.70 per common share with a term expiring June 30, 2026.

  December 1, 2017

   · 

  4 min read
• Novocure Receives Reimbursement Approval for Optune in Japan for the Treatment of Newly Diagnosed Glioblastoma

  Optune is a noninvasive, portable device approved in Japan to treat newly diagnosed and recurrent GBM.

  December 1, 2017

   · 

  7 min read
• Business

  Stellar Biotechnologies Reports Fiscal Year 2017 Financial Results

  During fiscal year 2017, the company advanced a number of strategic initiatives to optimize its manufacturing operations and to secure additional locations for the biologic source of KLH.

  December 1, 2017

   · 

  14 min read
• Business

  Daiichi Sankyo and Translational Sciences Conclude Agreement, After Successful Phase 1a Trial, as Part of Daiichi Sankyo Portfolio Prioritization

  Daiichi Sankyo will return all rights to develop and commercialize Translational Sciences’ investigational thrombus dissolving agent, TS23, after a successful Phase 1a clinical trial.

  December 1, 2017

   · 

  2 min read
• Policy

  Life Sciences Ontario Launches Blueprint for Coordinated Ontario Life Sciences Strategy

  The document is endorsed by leading provincial and national life sciences, health, and economic organizations.

  December 1, 2017

   · 

  2 min read
• Business

  Prime Therapeutics Signs CareCentered Contract With Leading Manufacturer of MS Drugs

  This contract places accountability on Biogen to deliver safety, efficacy, and value for the patients who receive these life-impacting therapies and for the payers who finance them.

  December 1, 2017

   · 

  2 min read
• Business

  sphingotec Announces Collaboration With Mayo Clinic for Evaluation and Use of Biomarkers to Improve Diagnosis of Certain Diseases, Including Kidney Disease, Breast Cancer, Sepsis, and Cardiovascular Disease

  Through this agreement, Mayo Clinic will evaluate the biomarkers penKid and three others for research and potential routine clinical use.

  December 1, 2017

   · 

  2 min read
• Business

  Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer

  Dr Heinonen joins Faron from AstraZeneca where he served as the Global Marketing Director for AstraZeneca/Medimmune’s Fasenra (benralizumab), first biologic medication launched from AZ respiratory unit.

  December 1, 2017

   · 

  3 min read
• Drug Development

  Photocure ASA: Blue Light Flexible Cystoscopy With Cysview Phase III Study: New Data Presented at Society of Urological Oncology

  Four separate posters were presented, including one using patient reported outcomes data from this study demonstrated the positive impact of Cysview on patient Quality of Life.

  December 1, 2017

   · 

  4 min read